Clinical Trial

Infection Surveillance of R/R Multiple Myeloma Patients Treated With Elranatamab as Clinical Practice in Italy

Name: Infection Surveillance of R/R Multiple Myeloma Patients Treated With Elranatamab as Clinical Practice in Italy — clinical trial record (NCT07564128)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: RISE

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to measure the infection rate and presentation pattern in first 12 months of therapy with elranatamab as standard clinical practice in adult patients with Relapsed/Refractory Multiple Myeloma.

Trial Details

NCT Number	NCT07564128
Lead Sponsor	Gruppo Italiano Malattie EMatologiche dell'Adulto
Conditions	Multiple Mieloma
Enrollment	50 participants
Start Date	2026-08
Primary Completion	2028-02 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2026-05-04